STRYKER CORP Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
STRYKER CORP (SYK) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $623.00 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-07-24.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2014-07-24
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-06-30 was -$60.00M.
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-03-31 was $683.00M, a 8.93% decline year-over-year.
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2013-12-31 was -$65.00M.
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2013-09-30 was -$2.00M.
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2013 was $683.00M, a 31.70% decline from fiscal 2012.
- STRYKER CORP stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $1.00B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2014-06-30 | -$60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $623.00M 10-Q · filed 2014-07-24 | $558.00M derived: sum of 3 quarters · filed 2014-07-24 | $556.00M derived: sum of 4 quarters · filed 2014-07-24 |
| 2014-03-31 | $683.00M 10-Q · filed 2014-04-24 | $618.00M derived: sum of 2 quarters · filed 2014-04-24 | $616.00M derived: sum of 3 quarters · filed 2014-04-24 | $616.00M derived: sum of 4 quarters · filed 2014-04-24 |
| 2013-12-31 | -$65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$67.00M derived: sum of 2 quarters · filed 2014-02-13 | -$67.00M derived: sum of 3 quarters · filed 2014-02-13 | $683.00M 10-K · filed 2014-02-13 |
| 2013-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$2.00M derived: sum of 2 quarters · filed 2013-10-23 | $748.00M 10-Q · filed 2013-10-23 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $750.00M 10-Q · filed 2013-07-23 | ||
| 2013-03-31 | $750.00M 10-Q · filed 2013-04-30 | |||
| 2012-12-31 | $1.00B 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |